Ascent Industries vs Balchem
ACNT and BCPC side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACNT and BCPC compare
Balchem is the larger company, worth 47 times as much as Ascent Industries ($5.5B against $117M).
Ascent Industries grew revenue faster over the last twelve months (22.4% versus 9.4% for Balchem).
Balchem keeps more of each dollar of sales as profit, with a net margin of 15.4% compared with −1.0% at Ascent Industries.
Balchem pays a dividend yielding 0.55%; Ascent Industries does not pay one.
Balchem scores higher on the StockData Score (19 against 12 for Ascent Industries), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACNT | BCPC |
|---|---|---|
| Size and price | ||
| Market cap | $117M | $5.5B |
| Share price | $13.02 | $173.14 |
| Change, 1 year | −4.9% | 10.1% |
| Change, 5 years | −2.7% | 3.4% |
| Beta (5Y) | 0.34 | 0.74 |
| Employees | 198 | 1,352 |
| StockData Score | ||
| Total score | 12 | 19 (better) |
| Valuation score | 2 | 2 |
| Growth score | 1 | 4 (better) |
| Performance score | 3 | 5 (better) |
| Health score | 6 | 6 |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | – | 32.6× |
| P/S | 1.3× (better) | 5.0× |
| P/B | 1.4× (better) | 4.1× |
| EV/EBITDA | – | 19.5× |
| PEG | – | 2.42 |
| FCF yield | −6.7% | – |
| Fair value | $14.67 | $151.06 |
| Margin of safety | 11.3% (better) | −14.6% |
| Growth | ||
| Revenue growth (TTM) | 22.4% (better) | 9.4% |
| Revenue growth, 5Y average | −21.8% | 8.1% (better) |
| Net income growth (TTM) | −208% | 14.5% (better) |
| EPS growth (TTM) | −200% | 16.2% (better) |
| EPS growth, 5Y average | – | 12.8% |
| Profitability | ||
| Gross margin | 20.8% | 36.5% (better) |
| Operating margin | −2.7% | 20.7% (better) |
| Net margin | −1.0% | 15.4% (better) |
| FCF margin | −8.7% | – |
| Return on equity | −1.1% | 13.0% (better) |
| Return on invested capital | −4.8% | 14.3% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 4.50 (better) | 2.47 |
| Altman Z-score | 4.59 | 11.06 (better) |
| Piotroski F-score | 7 | 9 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | 0.55% (better) |
| Payout ratio | – | 18.0% |
| Years of dividend growth | 0 | 3 (better) |
| Buyback yield | 6.1% (better) | 2.3% |
| Shareholder yield | 6.1% (better) | 2.8% |
| Ownership | ||
| Held by institutions | 56.3% | 91.3% |
| Held by insiders | 13.8% | 0.72% |
| Insider net buying, 12 months | $123K (better) | −$2.2M |
| Short interest, % of float | 1.9% | 1.6% |
Go deeper
- ACNT stock overview
- ACNT income statement
- ACNT valuation and score
- BCPC stock overview
- BCPC income statement
- BCPC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.